/
Sulforaphane prevents and reverses allergic airways disease in mice via anti-inflammatory, antioxidant, and epigenetic mechanisms
- Royce, Simon G., Licciardi, Paul V., Pitsillou, Eleni, Siow, Ya Yun, Snibson, Kenneth J., Tobin, Mark J., Ververis, Katherine, Vongsvivut, Jitraporn, Ziemann, Mark, Samuel, Chrishan S., Tang, Mimi L. K., El-Osta, Assam, Beh, Raymond C., Karagiannis, Tom C., Bourke, Jane E., Donovan, Chantal, Hung, Andrew, Khurana, Ishant, Liang, Julia J., Maxwell, Scott, Mazarakis, Nadia
Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen
- Thorburn, Alison N., Brown, Alexandra C., Nair, Prema M., Chevalier, Nina, Foster, Paul S., Gibson, Peter G., Hansbro, Philip M.
Novel therapeutic approaches for the treatment of allergic airways disease
- Collison, Adam Michael
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
- Preston, J. A., Thorburn, A. N., Foster, P. S., Hansbro, P. M., Starkey, M. R., Beckett, E. L., Horvat, J. C., Wade, M. A., O'Sullivan, B. J., Thomas, R., Beagley, K. W., Gibson, P. G.
A Streptococcus pneumoniae-based immunoregulatory therapy for asthma
- Thorburn, Alison
Are you sure you would like to clear your session, including search history and login status?